DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Return 10.85%
This Quarter Return
+9.47%
1 Year Return
-10.85%
3 Year Return
+35.19%
5 Year Return
+71.7%
10 Year Return
AUM
$2.08B
AUM Growth
+$273M
Cap. Flow
+$121M
Cap. Flow %
5.83%
Top 10 Hldgs %
26.49%
Holding
390
New
18
Increased
114
Reduced
180
Closed
13

Sector Composition

1 Technology 15.7%
2 Healthcare 10.65%
3 Financials 8.79%
4 Consumer Discretionary 7.14%
5 Consumer Staples 7.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STAB
376
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$34K ﹤0.01%
14,675
RGLS
377
DELISTED
Regulus Therapeutics
RGLS
$4K ﹤0.01%
1,200
ARCC icon
378
Ares Capital
ARCC
$15.7B
-10,620
Closed -$216K
ARKK icon
379
ARK Innovation ETF
ARKK
$7.36B
-6,289
Closed -$695K
BCAB icon
380
BioAtla
BCAB
$28.3M
-7,592
Closed -$224K
BIV icon
381
Vanguard Intermediate-Term Bond ETF
BIV
$24.1B
-4,129
Closed -$369K
IYF icon
382
iShares US Financials ETF
IYF
$4.06B
-2,470
Closed -$204K
MFC icon
383
Manulife Financial
MFC
$52.3B
-14,938
Closed -$287K
MUB icon
384
iShares National Muni Bond ETF
MUB
$38.6B
-2,128
Closed -$247K
NAC icon
385
Nuveen California Quality Municipal Income Fund
NAC
$1.63B
-11,588
Closed -$182K
TROW icon
386
T Rowe Price
TROW
$24.6B
-1,110
Closed -$218K
VCYT icon
387
Veracyte
VCYT
$2.43B
-4,400
Closed -$204K
TWTR
388
DELISTED
Twitter, Inc.
TWTR
-3,434
Closed -$207K
ADMS
389
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
-16,000
Closed -$79K
GPX
390
DELISTED
GP Strategies Corp.
GPX
-13,040
Closed -$270K